Daniel D. Karp
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 66
- Cancer Immunotherapy and Biomarkers 26
- Colorectal Cancer Treatments and Studies 8
-
- Lung Cancer Treatments and Mutations 27
- Lung Cancer Diagnosis and Treatment 15
- Co-authors
- Waun Ki Hong (7 shared papers)R. Lotan (2 shared papers)Philip Bonomi (3 shared papers)Everett E. Vokes (5 shared papers)Mark S. Huberman (3 shared papers)David R. Gandara (4 shared papers)Vincent A. Miller (5 shared papers)James R. Rigas (1 shared paper)
- Journals
- Cancer (15 papers)Clinical Cancer Research (13 papers)Annals of Oncology (10 papers)Investigational New Drugs (9 papers)Journal of Clinical Oncology (9 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Daniel D. Karp
184 papers receiving 14.1k citations
Daniel D. Karp's Hit Papers
Peers
Comparison fields: 5 of 138
- Pulmonary and Respiratory Medicine 4.1k
- Oncology 2.6k
- Biochemistry 729
- Otorhinolaryngology 552
- Cancer Research 1.3k
Countries citing papers authored by Daniel D. Karp
This map shows the geographic impact of Daniel D. Karp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel D. Karp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel D. Karp more than expected).
Fields of papers citing papers by Daniel D. Karp
This network shows the impact of papers produced by Daniel D. Karp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel D. Karp. The network helps show where Daniel D. Karp may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel D. Karp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 186 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers Hit paper breakdown → | 2008 | 1734 |
| 2 | Vitamin E and the Risk of Prostate Cancer Hit paper breakdown → | 2011 | 1450 |
| 3 | Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens Hit paper breakdown → | 2000 | 1197 |
| 4 | Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and Neck Hit paper breakdown → | 1990 | 1173 |
| 5 | A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal Cancer Hit paper breakdown → | 2003 | 959 |
| 6 | Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer Hit paper breakdown → | 2004 | 924 |
| 7 | 1993 | 312 | |
| 8 | 2005 | 301 | |
| 9 | Targeting RET in Patients With RET -Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry Hit paper breakdown → | 2017 | 301 |
| 10 | 2016 | 283 | |
| 11 | Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trials Hit paper breakdown → | 2023 | 278 |
| 12 | 2001 | 260 | |
| 13 | 1993 | 248 | |
| 14 | 2016 | 200 | |
| 15 | 2005 | 183 | |
| 16 | 1996 | 172 | |
| 17 | Differentiation patterns in the blastic phase of chronic myeloid leukemia. | 1983 | 171 |
| 18 | 2016 | 167 | |
| 19 | 2020 | 143 | |
| 20 | 2017 | 142 |
About Daniel D. Karp
Daniel D. Karp is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Otorhinolaryngology, having authored 186 papers that have together received 14.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (27 papers), Cancer Immunotherapy and Biomarkers (26 papers), Cancer Genomics and Diagnostics (18 papers), Lung Cancer Diagnosis and Treatment (15 papers), PI3K/AKT/mTOR signaling in cancer (10 papers), Colorectal Cancer Treatments and Studies (8 papers), Head and Neck Cancer Studies (7 papers) and Nuclear Structure and Function (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (4.1k citations), Oncology (2.6k citations), Biochemistry (729 citations), Otorhinolaryngology (552 citations) and Cancer Research (1.3k citations). Daniel D. Karp has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Waun Ki Hong, R. Lotan, Philip Bonomi, Everett E. Vokes, Mark S. Huberman, David R. Gandara, Vincent A. Miller, James R. Rigas, Lisa A. Hammond and David S. Hong. Their work appears in journals such as Cancer, Clinical Cancer Research, Annals of Oncology, Investigational New Drugs and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.